1, 3-oxazolidin-2-one derivatives useful as CETP inhibitors

Details for Australian Patent Application No. 2006332681 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Li, Hong; Sinclair, Peter J.; Smith, Cameron J.; Lu, Zhijian; Ali, Amjad; Chen, Yi-Heng

Agent Spruson & Ferguson

Pub. Number AU-B-2006332681

PCT Pub. Number WO2007/079186

Priority 60/755,284 30.12.05 US

Filing date 29 December 2006

Wipo publication date 12 July 2007

Acceptance publication date 7 April 2011

International Classifications

C07D 263/22 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/443 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/079186 Priority application(s): WO2007/079186

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 April 2011 Application Accepted

  Published as AU-B-2006332681

4 August 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006332690-Gastric retentive gabapentin dosage forms and methods for using same

2006332680-Improved composition for collecting and preserving placental stem cells and methods of using the composition